ARCHIVES

As patients worry about COX-2 inhibitors, scientists and FDA review toxicity data.

This article is from The Cancer Letter archive.

Vol. 30 No. 40 | October 22, 2004

Download PDF Visit The Full Archive

Related Articles

Broder Not Satisfied With Mortality STATS On Three Major Cancers

September 20, 1991

When Doctors Take Work Home: Houston Burglary Points to Security Breach

June 29, 2012

Conversation with TCL:Demetri: Morcellation Worsens Outcomes In Patients with Undiagnosed Cancers

November 21, 2014

In Brief: Healy Nominated to Head NIH; Hammond, D’Angio To Step Down as Group Chairman

January 18, 1991

Final Issue of ‘78

December 15, 1978

DCE director Adamson To Retire August 31

June 3, 1994